Recombinant Activated Factor VIIa Combined With Tranexamic Acid Control Haemostasis in Patients With Severe Factor XI Deficiency Undergoing Urological Procedures
Combination of low-dose rFVIIa with TXA is a feasible and attractive option for patients undergoing urologic procedures. Further implications of this protocol should be implemented in clinical practice.
Authors
- Neta Sternbach
- Jack Baniel
- Galia Spectre
- Daniel Saidian
- Yaron Ehrlich
- Pia Raanani (ORCID: https://orcid.org/0000-0001-9973-639X)
- Anfisa Stenevsky
- Darawsha Abd Elhalim
Institutions
- Tel Aviv University (IL)
- Rabin Medical Center (IL)
- Meir Medical Center (IL)
Publication Details
- Journal
- Haemophilia
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1111/hae.70052
- Citations
- 2
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 3.25